Oncolytics Biotech, Inc.
(Toronto Stock Exchange : ONCY)

( )
ONCY PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 0.07%67.611.0%$1048.91m
BIIBBiogen, Inc. 2.70%342.001.5%$718.24m
AMGNAmgen, Inc. -0.62%222.091.3%$585.61m
ILMNIllumina, Inc. 2.59%298.923.5%$440.19m
REGNRegeneron Pharmaceuticals, Inc. -0.45%397.742.6%$385.35m
VRTXVertex Pharmaceuticals, Inc. -0.74%242.011.9%$346.26m
ALXNAlexion Pharmaceuticals, Inc. 0.00%102.562.0%$208.61m
EXASEXACT Sciences Corp. 3.61%98.1824.0%$165.42m
AAgilent Technologies, Inc. 0.20%86.011.6%$151.72m
SGENSeattle Genetics, Inc. -0.13%118.076.1%$116.25m
MRNAModerna, Inc. -0.05%18.990.0%$111.22m
INCYIncyte Corp. -0.57%78.002.5%$100.64m
XLRNAcceleron Pharma, Inc. -0.48%93.666.1%$99.78m
SRPTSarepta Therapeutics, Inc. 0.31%125.4214.6%$97.24m
BMRNBioMarin Pharmaceutical, Inc. 0.87%89.014.3%$93.97m

Company Profile

Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.